Copyright © 2005, European Society of Cardiology
Reduced neointima in vein grafts following a blockage of cell recruitment from the vein and the surrounding tissue
aWallenberg Laboratory for Cardiovascular Research, The Cardiovascular Institute, The Sahlgrenska Academy at Göteborg University, Gothenburg, Sweden
bDepartment of Vascular Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden
* Corresponding author. Sahlgrenska University Hospital, Bruna sträket 11B, plan 1. Department of Vascular Surgery, SE-413 45 Gothenburg, Sweden. Tel.: +46 31 342 10 00; fax: +46 31 82 72 36. Email address: erney.mattsson{at}wlab.gu.se
Objective: Accumulation of intimal smooth muscle cells (SMC) is an important event in vein graft-stenosis. Different SMC sources have been reported, but their interrelations have been poorly studied. In a mouse vein graft model we investigated whether recipient-derived intimal SMCs are recruited from the surrounding tissue and whether blockage of SMC recruitment from the surrounding tissue and/or the donor vein will reduce neointimal formation.
Methods: To detect recipient-derived cells, wild-type veins were implanted into ROSA26 transgenic mice. To block cell recruitment from the surrounding tissue, implanted veins were isolated with a tube-shaped plastic film. To exclude vein-derived cells in the neointimal formation, acellular veins were implanted.
Results: In vein grafts isolated from the surrounding tissue the recipient contribution became minimal, but the total number of SMCs was not decreased. Acellular grafts contained an equal number of intimal SMCs as cellular controls after 4 weeks. Isolation of acellular grafts from the surrounding tissue decreased the number of intimal SMCs by 90%.
Conclusions: Recipient-derived SMCs are mainly recruited from the surrounding tissue. Cell recruitment from either the vein or the surrounding tissue is enough to form a neointima. Therefore, a simultaneous inhibition of both these sources is needed to reduce accumulation of intimal SMCs.
KEYWORDS Cardiovascular surgery; Veins; Remodeling; Smooth muscle
Time for primary review 20 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Fogelstrand, C. C. Feral, R. Zargham, and M. H. Ginsberg Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2) J. Exp. Med., October 26, 2009; 206(11): 2397 - 2406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Mitchell and P. Libby Vascular Remodeling in Transplant Vasculopathy Circ. Res., April 13, 2007; 100(7): 967 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Schachner, G. Laufer, and J. Bonatti In vivo (animal) models of vein graft disease. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 451 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Schachner Pharmacologic inhibition of vein graft neointimal hyperplasia J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1065 - 1072. [Abstract] [Full Text] [PDF]
|
|